Sequent Scientific is currently trading at Rs. 78.00, up by 0.35 points or 0.45% from its previous closing of Rs. 77.65 on the BSE.
The scrip opened at Rs. 81.50 and has touched a high and low of Rs. 81.50 and Rs. 78.00 respectively. So far 405 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 95.00 on 04-Jul-2011 and a 52 week low of Rs. 50.30 on 10-Oct-2011.
Last one week high and low of the scrip stood at Rs. 85.00 and Rs. 74.60 respectively. The current market cap of the company is Rs. 171.09 crore.
The promoters holding in the company stood at 55.57% while Institutions and Non-Institutions held 0.01% and 44.42% respectively. Sequent Scientific’s Panoli facility has encountered with fire on February 03, 2012. There has been no loss of life or injury to personnel due to fire. Further, the cause of fire is being investigated and the damage on account of the accident is being assessed for which the company has adequate insurance cover.
Sequent Scientific is a leading manufacturer, exporter of specialized quality formulations having an objective of fulfilling the diverse demands of pharmaceutical industry. It specializes in the manufacturing of the formulation belonging to anthelmintic and anti-parasitic segment.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1787.10 |
| Dr. Reddys Lab | 1271.75 |
| Cipla | 1376.25 |
| Zydus Lifesciences | 1097.90 |
| Lupin | 2248.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: